A duo of former executives from beleaguered drug maker Valeant and its defunct mail order pharmacy Philidor have been found guilty of a multimillion dollar fraud – and the f
Valeant has sold its controversial female libido drug to former shareholders in Sprout, the company that first developed it before a $1 billion buyout two years ago.
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS